Table 3.
Cells | Source | Advantages | Disadvantages | References |
---|---|---|---|---|
Tissue-specific primary cells |
Tissue-specific stem/progenitor cells (e.g.; brain, spinal cord, heart, skin, hair follicle) | Reduced risk of rejection (autologous) | Small quantities especially medically fragile patients limited proliferation capacity difficult to obtain |
[120,121] |
Mesenchymal stem cells (MSC) | Bone marrow Peripheral blood Adipose tissue Placenta Umbilical cord |
Multipotency Immunomodulatory properties, Well-characterized |
Differentiation potential decreases with increasing age | [114,115,116,120] |
Induced pluripotent stem cells (iPSC) | Reprogram from dermal fibroblasts or peripheral blood | Pluripotentcy, indefinite self-renewal Patient-specific |
Risk of in vivo teratoma formation Streamlined differentiation protocols needed Possible genetic mutations |
[117,118,122] |